开云app官网登录入口网页版-官方正版

#肿瘤学#

134篇内容 | 2934人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2196850, encodeId=bd052196850dc, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a> <a href='/topic/show?id=d3a024808e0' target=_blank style='color:#2F92EE;'>#人工智能#</a>, objectTitle=人工智能在肿瘤学中的应用及其局限性, objectType=article, longId=820163, objectId=465d82016340, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230321/1679467047448_4754896.jpeg, objectUrl=/article/show_article.do?id=465d82016340, replyNumber=0, likeNumber=65, createdTime=2024-04-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=465d82016340, moduleTitle=人工智能在肿瘤学中的应用及其局限性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=465d82016340)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1390835, encodeId=f7db1390835da, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=一线治疗晚期肝癌哪家强？《柳叶刀肿瘤学》发布卡博替尼+阿替利珠单抗 vs 索拉非尼III期临床结果, objectType=article, longId=731375, objectId=9d30e31375a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d30e31375a9, replyNumber=0, likeNumber=97, createdTime=2022-07-07, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d30e31375a9, moduleTitle=一线治疗晚期肝癌哪家强？《柳叶刀肿瘤学》发布卡博替尼+阿替利珠单抗 vs 索拉非尼III期临床结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9d30e31375a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390834, encodeId=0c1c1390834dc, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果, objectType=article, longId=730533, objectId=3dfde3053389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfde3053389, replyNumber=0, likeNumber=89, createdTime=2022-06-28, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfde3053389, moduleTitle=Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3dfde3053389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390833, encodeId=7fc2139083322, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=陈占红教授：中国临床肿瘤学会(CSCO）肿瘤放化疗相关中粒细胞减少症规范化管理指南（2021版）更新解读, objectType=article, longId=730239, objectId=a7f1e30239a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f1e30239a4, replyNumber=0, likeNumber=60, createdTime=2022-06-24, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f1e30239a4, moduleTitle=陈占红教授：中国临床肿瘤学会(CSCO）肿瘤放化疗相关中粒细胞减少症规范化管理指南（2021版）更新解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a7f1e30239a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390832, encodeId=700a1390832e4, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布, objectType=article, longId=728850, objectId=e55ee2885022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55ee2885022, replyNumber=0, likeNumber=82, createdTime=2022-06-09, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55ee2885022, moduleTitle=君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e55ee2885022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390831, encodeId=b7a91390831d4, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=ASTRO 2022：中山医院放疗科团队在世界放射肿瘤学舞台发出“中山声音”, objectType=article, longId=728735, objectId=7cd8e2873515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cd8e2873515, replyNumber=0, likeNumber=87, createdTime=2022-06-08, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cd8e2873515, moduleTitle=ASTRO 2022：中山医院放疗科团队在世界放射肿瘤学舞台发出“中山声音”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7cd8e2873515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390830, encodeId=8a4e139083063, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果, objectType=article, longId=728477, objectId=a6b9e2847722, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6b9e2847722, replyNumber=0, likeNumber=80, createdTime=2022-06-03, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6b9e2847722, moduleTitle=武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a6b9e2847722)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390829, encodeId=db7f1390829e2, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏, objectType=article, longId=728328, objectId=9b53e28328a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b53e28328a2, replyNumber=0, likeNumber=71, createdTime=2022-06-02, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b53e28328a2, moduleTitle=【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b53e28328a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390828, encodeId=b8571390828bc, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, objectType=article, longId=727390, objectId=19e3e2739016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e3e2739016, replyNumber=0, likeNumber=65, createdTime=2022-05-21, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e3e2739016, moduleTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=19e3e2739016)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390827, encodeId=4224139082e40, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=深浸润子宫内膜样腺癌前哨淋巴结（SLN）示踪与系统淋巴结切除的肿瘤学结局, objectType=article, longId=724861, objectId=a1e6e2486192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1e6e2486192, replyNumber=0, likeNumber=91, createdTime=2022-04-25, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1e6e2486192, moduleTitle=深浸润子宫内膜样腺癌前哨淋巴结（SLN）示踪与系统淋巴结切除的肿瘤学结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a1e6e2486192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390826, encodeId=fed71390826a3, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=2021CCO中国肿瘤学大会精彩回放, objectType=article, longId=724258, objectId=eb2ee24258a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb2ee24258a0, replyNumber=0, likeNumber=56, createdTime=2022-04-15, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb2ee24258a0, moduleTitle=2021CCO中国肿瘤学大会精彩回放, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=eb2ee24258a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390825, encodeId=5cf813908254b, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=知临集团宣布推出针对未解决的突变和新型生物标志物的肿瘤学和自身免疫发现和开发平台, objectType=article, longId=293896, objectId=5ae2293896b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae2293896b4, replyNumber=0, likeNumber=91, createdTime=2022-01-14, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae2293896b4, moduleTitle=知临集团宣布推出针对未解决的突变和新型生物标志物的肿瘤学和自身免疫发现和开发平台, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5ae2293896b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390824, encodeId=9209139082489, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=ESMO OPEN：COVID-19背景下肿瘤学临床试验的新操作方法和地理差异, objectType=article, longId=293039, objectId=28fc2930390b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28fc2930390b, replyNumber=0, likeNumber=0, createdTime=2021-12-30, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28fc2930390b, moduleTitle=ESMO OPEN：COVID-19背景下肿瘤学临床试验的新操作方法和地理差异, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=28fc2930390b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390823, encodeId=3c4113908236f, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=临床肿瘤学教学模式的问题及改进措施, objectType=article, longId=221281, objectId=a2ae221281d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2ae221281d0, replyNumber=0, likeNumber=78, createdTime=2021-12-01, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2ae221281d0, moduleTitle=临床肿瘤学教学模式的问题及改进措施, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a2ae221281d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390822, encodeId=7931139082213, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2021版更新解读, objectType=article, longId=220817, objectId=72d122081eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72d122081eef, replyNumber=0, likeNumber=0, createdTime=2021-11-24, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72d122081eef, moduleTitle=中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2021版更新解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=72d122081eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390821, encodeId=486413908215b, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=中国临床肿瘤学会（CSCO）结直肠癌诊疗指南, objectType=article, longId=220749, objectId=6624220e496e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6624220e496e, replyNumber=0, likeNumber=68, createdTime=2021-11-23, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6624220e496e, moduleTitle=中国临床肿瘤学会（CSCO）结直肠癌诊疗指南, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6624220e496e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390820, encodeId=64ee1390820ec, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=肿瘤学期刊推荐：The International Journal of Biological Markers, objectType=article, longId=218027, objectId=ce2b21802ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce2b21802ea4, replyNumber=0, likeNumber=61, createdTime=2021-10-03, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce2b21802ea4, moduleTitle=肿瘤学期刊推荐：The International Journal of Biological Markers, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ce2b21802ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390819, encodeId=ec4c139081945, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=肿瘤学期刊推荐：INTEGRATIVE CANCER THERAPIES, objectType=article, longId=218026, objectId=11ee2180264a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11ee2180264a, replyNumber=0, likeNumber=68, createdTime=2021-10-03, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11ee2180264a, moduleTitle=肿瘤学期刊推荐：INTEGRATIVE CANCER THERAPIES, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=11ee2180264a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390818, encodeId=7656139081878, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=【转播回放】全体大会日程公布| 第二十四届全国临床肿瘤学大会暨2021年CSCO学术年会, objectType=article, longId=217691, objectId=e6a221e6915e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6a221e6915e, replyNumber=0, likeNumber=0, createdTime=2021-09-28, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6a221e6915e, moduleTitle=【转播回放】全体大会日程公布| 第二十四届全国临床肿瘤学大会暨2021年CSCO学术年会, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e6a221e6915e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390817, encodeId=2b13139081eb3, content=<a href='/topic/show?id=8eeb828963a' target=_blank style='color:#2F92EE;'>#肿瘤学#</a>, objectTitle=肿瘤学术公益讲堂大咖云集免费授课肺小节的筛查，随诊及干预 8月5日场, objectType=article, longId=215290, objectId=4f9021529049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f9021529049, replyNumber=0, likeNumber=81, createdTime=2021-08-06, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f9021529049, moduleTitle=肿瘤学术公益讲堂大咖云集免费授课肺小节的筛查，随诊及干预 8月5日场, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4f9021529049)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

肿瘤学

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肿瘤学# #人工智能#

人工智能在肿瘤学中的应用及其局限性

2024-04-03发表于陕西省

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

一线治疗晚期肝癌哪家强？《柳叶刀肿瘤学》发布卡博替尼+阿替利珠单抗 vs 索拉非尼III期临床结果

2022-07-07

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果

2022-06-28

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

陈占红教授：中国临床肿瘤学会(CSCO）肿瘤放化疗相关中粒细胞减少症规范化管理指南（2021版）更新解读

2022-06-24

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布

2022-06-09

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

ASTRO 2022：中山医院放疗科团队在世界放射肿瘤学舞台发出“中山声音”

2022-06-08

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果

2022-06-03

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

【精彩呈现】2022美国临床肿瘤学会（ASCO）年会专栏

2022-06-02

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测

2022-05-21

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

深浸润子宫内膜样腺癌前哨淋巴结（SLN）示踪与系统淋巴结切除的肿瘤学结局

2022-04-25

一叶知秋 (审核中...)

前往app查看评论内容

#肿瘤学#

2021CCO中国肿瘤学大会精彩回放

2022-04-15

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

知临集团宣布推出针对未解决的突变和新型生物标志物的肿瘤学和自身免疫发现和开发平台

2022-01-14

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

ESMO OPEN：COVID-19背景下肿瘤学临床试验的新操作方法和地理差异

2021-12-30

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

临床肿瘤学教学模式的问题及改进措施

2021-12-01

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2021版更新解读

2021-11-24

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

中国临床肿瘤学会（CSCO）结直肠癌诊疗指南

2021-11-23

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

肿瘤学期刊推荐：The International Journal of Biological Markers

2021-10-03

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

肿瘤学期刊推荐：INTEGRATIVE CANCER THERAPIES

2021-10-03

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

【转播回放】全体大会日程公布| 第二十四届全国临床肿瘤学大会暨2021年CSCO学术年会

2021-09-28

108807375_62823127 (审核中...)

前往app查看评论内容

#肿瘤学#

肿瘤学术公益讲堂大咖云集免费授课肺小节的筛查，随诊及干预 8月5日场

2021-08-06

科室
- - 订阅+
  - 更多科室
工具
服务